As of 1:30 PM on the 23rd, Komipharm is trading at 12,750 KRW, the same price as the previous day. This represents an 18.79% decline compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net sellers of 1,203 shares. Over the past five days, individual investors have net sold 87,408 shares, while foreigners and institutions have net bought 71,230 shares and 16,866 shares, respectively.
On October 14, Komipharm became a market issue with a sharp drop following the news of 'Rejection of clinical trial application for COVID-19 treatment in Spain.'
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
